Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Shocking Report Reveals That Some Leading Fish Oil Supplements Don’t Live Up to Their Claims
  • USA - English


News provided by

DTI UG

Feb 20, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Dr. Tobias Optimum Omega 3 Fish Oil, ranked #1 for quality in the independent research of LabDoor
Dr. Tobias Optimum Omega 3 Fish Oil, ranked #1 for quality in the independent research of LabDoor

Trittau, Schleswig-Holstein (PRWEB) February 20, 2014 -- Some of the most popular Omega 3 fish oil supplements sold in America do not live up to the claims made on their labels.

In a shocking case of “buyer beware”, research by a trusted independent lab discovered that seven out of 30 leading brands contained levels of Omega 3s that were an average of 20 percent less than the total amount declared.

At least eight products contained less of either docosahexaenoic (DHA) or eicosapentaenoic acid (EPA) than claimed on packaging.

LabDoor rated Dr. Tobias Optimum Omega 3 as the highest quality Omega 3 fish oil supplement in the U.S.

Post this

The study was conducted by San Francisco-based LabDoor, a company partly funded by investor Mark Cuban and by nonprofit digital health incubator, Rock Health.

Researchers compared products based on their label accuracy, manufacturing purity, nutritional value, ingredient safety, and projected efficacy. With the fish oil products they were particularly interested in the levels of mercury and the extent to which the products displayed any indications of rancidity or deterioration.

One product that came under scrutiny and passed with flying colors was Dr. Tobias Optimum Omega 3 Fish Oil which LabDoor rated as the highest quality Omega 3 fish oil supplement in the U.S. The Dr. Tobias product, which is made from the best quality coldwater fish, beat out all of the competition, including products made by national nutritional chains. It was also rated number six for value.

Optimum Omega 3 contains three to five times more DHA and eicosapentaenoic acid (EPA) than most other brands in the market. It is purified through one of the most sophisticated molecular distillation processes available and also enteric coated so there’s a reduced fishy aftertaste, while there is optimal absorption.

Dr. Tobias Ihde, CEO and president of German company DTI UG, developed his Optimum Omega 3 Fish Oil after discovering that fish oil helped his back and joint pain. He felt that the dosage of existing products was too low and he had concerns about their quality. Concerns that have turned out to be justified.

Dr. Ihde said, “It’s quite shocking to see the LabDoor research showing that some major brands do not live up to the claims on their labels. I’m delighted such a prestigious independent lab validated the superb quality of our product ranking it as number one. It’s gratifying to have this wonderful seal of approval and to be acknowledged as the very best.”

Dr. Oz calls Omega 3 the single most important supplement and of the 30 top brands tested, Optimum Omega-3 was the only tested product that meets his recommendation of 600 mg of DHA a day in just one serving.

Numerous studies have shown that Omega 3 fish oil supplements protect against heart disease and are also essential for the health of the brain and nervous system, skin and hair. Benefits have also been seen for the joints, eyes and immune system. Additionally, Omega 3s may lower the risk of Alzheimer’s disease.

Added Dr. Ihde, “Much of how healthy and happy we feel is determined by what we eat and what we do. Supplements like Optimum Omega 3 Fish Oil provide essential elements that are often missing from our daily diet.”

Dr. Ihde provides free health and activity videos “since diet and activity are two sides of the same coin.”

For more information visit: http://www.optimumomega3.com or http://www.amazon.com/Omega-Fish-Pills-Counts-Health-Supporting/dp/B00CAZAU62.

About DTI UG

DTI UG is a new company that’s setting new standards in the premium food supplement market. Its hallmark product Dr. Tobias Optimum Omega-3 Fish Oil has been rated as the “highest quality” product of its kind in the U.S.

DTI UG is dedicated to supporting its customers' health and happiness in today’s fast-paced world. CEO and President Dr. Tobias Ihde has a background in Sports Science and Sports and Medicine research and a doctorate in economics.

Paul Teggart, DTI UG, http://www.drtobias.net, +1 3477325329, [email protected]

Modal title

Dr. Tobias Optimum Omega 3 Fish Oil Supplement
Dr. Tobias Optimum Omega 3 Fish Oil Supplement
Dr. Tobias Optimum Omega 3 Fish Oil Supplement

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.